|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||151.69 - 153.29|
|52 Week Range||71.46 - 167.86|
|PE Ratio (TTM)||146.07|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Vetr crowd on Wednesday downgraded its rating of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) from 5 stars (Strong Buy), issued 15 days ago, to 1 star (Strong Sell). Crowd sentiment at the time ...
The Zacks Analyst Blog Highlights: iShares Core S&P 500 ETF, Vertex Pharmaceuticals, Align Technology, NRG Energy and Activision Blizzard
When investors follow sustained moves in either direction, they develop the "floating index syndrome."